Minnesota's abortion providers had been bracing for weeks for a ruling expected to complicate the future of one of the drugs used in medication abortions.
That ruling landed in early April, when U.S. District Court Judge Matthew Kacsmaryk in Texas ordered a hold on federal approval of mifepristone, a decision that overruled more than two decades of authorization of the drug.
While abortion is still legal in Minnesota, abortion rights advocates say the ruling has the potential to be even more consequential in the state than the overturning of Roe v. Wade last summer. More than half of abortions in the state are done through the use of a medication regimen that includes mifepristone.
"This judge has reached across state lines and brought the abortion crisis to Minnesota and every other state that still protects abortion rights," Megan Peterson, executive director of Gender Justice, an abortion rights legal nonprofit, said after the ruling.
Abortion opponents in Minnesota celebrated the Texas ruling, arguing the U.S. Food and Drug Administration (FDA) improperly approved the drug more than 20 years ago and then expanded access to the medication by mail and in pharmacies.
"Judge Kacsmaryk is right to recognize the major flaws in mifepristone's approval process," Minnesota Citizens Concerned for Life Co-Executive Director Cathy Blaeser said in a statement.
But the ruling doesn't mean access to mifepristone will end immediately, and a conflicting order issued by a different judge in Washington could affect the availability of the drug in Minnesota. State abortion providers also say they're prepared with an alternative for Minnesotans seeking medication abortion.
Here are some answers about what's next in Minnesota following the dueling court rulings.